Considering the central functions of lactate in immune suppression and tumor immune evasion, targeting lactate dehydrogenase A (LDHA) represents a promising strategy for enhancing the efficacy of cancer immunotherapy (Figure 4). This evidence concerns the gene LDHA and neoplasm.